Back to Top Skip to main content Skip to sub-navigation

Hepburn: DOD role in Operation Warp Speed was ‘transformative’

Image of Medical technician getting a syringe ready to give a vaccine. Click to open a larger version of the image. Crystal Tyler, pharmacy technician, prepares an injection for an Operation Warp Speed patient volunteer at Brooke Army Medical Center Fort Sam Houston, Texas, November 16, 2020. BAMC is one of five Defense Health Agency military medical treatment facilities participating in the Phase III trial to evaluate the vaccine under development by AstraZeneca as part of a national initiative to accelerate the development, production and distribution of COVID-19 vaccines, therapeutics and diagnostics. (Photo by Jason Edwards, Brooke Army Medical Center.)

Recommended Content:

COVID-19 Vaccine Efforts | Vaccine Trials | Coronavirus | Coronavirus and the COVID-19 Vaccine

The director of the Department of Defense’s Operation Warp Speed told The Society of Federal Health Professionals that he is 'incredibly proud’ of the work his team has done with the Department of Health and Human Services in finding a vaccine for COVID-19. Dr. Matthew Hepburn’s praise for DOD came during a speech to the AMSUS virtual annual meeting Dec. 8.

The DOD’s role in Operations Warp Speed (OWS) was “transformative,” said Hepburn, OWS development lead, pointing to operational planning, logistics and supply chains, which “is in our DNA” at DOD. “It comes very naturally because that is what we do…and that has made all the difference,” he told the audience of more than 1,500 online attendees.

For example, he said DOD’s expertise in obtaining contracts quickly resulted in OWS getting “a really good deal in record time that was mutually beneficial” to the six vaccine manufacturers the joint operation decided to pursue for an approved vaccine for COVID-19. Those manufacturers are Pfizer, Moderna, AstraZeneca, Janssen, Novavax, and Sanofi.

“The Department of Defense’s unique contracting experience … and other transactions have allowed us to come from where we think are the right contacts to having long-term contracts,” Hepburn said.

Pfizer and Moderna have applied for emergency use authorization from the Food and Drug Administration. Pfizer’s application will be reviewed by an FDA advisory committee of vaccine experts Dec. 10, and Moderna’s application will be reviewed a week later. The FDA usually, but not always, accepts its advisory panels’ recommendations.

The FDA announced on Dec. 8 that its review of the Pfizer vaccine found it to be safe and efficacious, meeting the requirements for emergency use authorization. The vaccine showed a strong protective effect after the first of two doses, according to the FDA.

The OWS’ chief operating officer, Army Gen. Gustave Perna, “has been very clear that we will have trucks rolling within 24 hours of approval of the first vaccine,” Hepburn said.

Once the vaccine is first available to frontline health care workers and elderly care facilities, “we need you to tell our communities that this is just one layer of a multi-level strategy” to protect against COVID-19, he stated.

He urged the health care community “to convey a message that these vaccines are safe and efficacious, and that vaccination is important” as a counterpoint to widespread misinformation in the general public about vaccines and the need for vaccination against the disease.

Clinical trials for the candidate vaccines are ongoing and represent the diversity of the general population, Hepburn said, and were done “in anticipation of trying to increase confidence” among the public. For example, at least 25% of clinical trial participants are over the age of 65, a population not normally used for clinical trials but one at greater risk from COVID-19, he noted.

The number of doses needed for immunizations is “really a moving target, which is not necessarily a bad thing,” Hepburn said. “The consistency and cadence of manufacturing improves over time, and more doses are available than we thought would be available last week.”

OWS’ project team asks for “more doses on a daily basis,” he noted.

Armed services research efforts prior to the pandemic will allow for future innovation and speed of vaccine and therapeutics development, Hepburn said.

“If we hadn’t made those investments 10 years ago, there is no way we could have achieved the speed” of going from research and development, to candidates, to clinical trials, to approval and distribution, he said.

He noted that the DOD’s “clinical research enterprise led us to be involved in the enrollment right now in the AstraZeneca clinical trials.”

He called the department’s research enterprise “an incredibly powerful tool to confront 21st century threats,” and that “this is the new standard for rapid product development, and will apply not only to pandemics but also to develop product for combat health in half the time. Imagine how fast we could go in force protection” using the new paradigm, he said.

During a question and answer session, Hepburn emphasized that the AMSUS audience “needs to remind people at the DOD and in the community at large how well DOD can work” when confronted by new viral or other national security and health care threats.

“One of the most important lessons learned is the value of military leadership” in overcoming obstacles at a rapid clip, he said, noting the DOD “didn’t take over a public health initiative, but collaborated on a project that involved not only what we’re doing for the American people but also globally.”

You also may be interested in...

Ventilator Basics - Part 2 (ACPC and PS) (March 25, 2020)

Video
5/11/2020
Ventilator Basics - Part 2 (ACPC and PS) (March 25, 2020)

This video is an introduction to pressure control and pressure support ventilator settings. If you have not yet viewed 'Vent Basics for Non-Intensivists (ACVC/VAC)", please watch that video first. This video is not intended to be all encompassing. It is intended to educate non-intensivists on basic vent settings and vent mechanics.

Recommended Content:

Coronavirus | Coronavirus and the COVID-19 Vaccine

Sedation and Analgesia in the ICU during COVID-19 (March 31, 2020)

Video
5/11/2020
Sedation and Analgesia in the ICU during COVID-19 (March 31, 2020)

This video is intended to assist healthcare providers with the care of critically ill patients only. It is to be used as a guide ONLY for patients who have breathing tubes and are mechanically ventilated (on breathing machines). It will introduce you to sedative and analgesic medications that are used in the intensive care unit setting only. It will provide recommendations for use of sedation and analgesia in standard settings, but it will also provide recommendations for use in resource limited

Recommended Content:

Coronavirus | Coronavirus and the COVID-19 Vaccine

Airway Pressure Release Ventilation (APRV) (April 17, 2020)

Video
5/11/2020
Airway Pressure Release Ventilation (APRV) (April 17, 2020)

This video will explain the basics of Airway Pressure Release Ventilation, an option for mechanical ventilation, that is helpful as an oxygen salvage therapy for patients with Acute Respiratory Distress Syndrome (ARDS).

Recommended Content:

Coronavirus | Coronavirus and the COVID-19 Vaccine

Multi-Dimensional Approach To Intubation In The Setting Of COVID-19 (April 1, 2020)

Video
5/11/2020
Multi-Dimensional Approach To Intubation In The Setting Of COVID-19 (April 1, 2020)

In this video, a doctor and nurse will talk you through preparing to intubate a patient. At the end of the video we highlight some special considerations for intubation in the context of COVID.

Recommended Content:

Coronavirus | Coronavirus and the COVID-19 Vaccine

Transport Vent Tutorial (ParaPAC) (March 25, 2020)

Video
5/11/2020
Transport Vent Tutorial (ParaPAC) (March 25, 2020)

Transport Vent Tutorial - ParaPAC

Recommended Content:

Coronavirus | Coronavirus and the COVID-19 Vaccine

IV Vasoactive Medication Basics for the Non Intensivist (March 19, 2020)

Video
5/11/2020
IV Vasoactive Medication Basics for the Non Intensivist (March 19, 2020)

This video provides a refresher/introduction to the basics of inotropes and vasopressors that may be helpful in the context of treating COVID-19 patients. It is not intended to be all-encompassing.

Recommended Content:

Coronavirus | Coronavirus and the COVID-19 Vaccine

Acute Respiratory Distress Syndrome Lecture (April 10, 2020)

Video
5/11/2020
Acute Respiratory Distress Syndrome Lecture (April 10, 2020)

In this lecture, the topic or Acute Respiratory Distress Syndrome is reviewed. Specific discussion on diagnosis and treatment including lung protective strategies are discussed.

Recommended Content:

Coronavirus | Coronavirus and the COVID-19 Vaccine

ICU Nursing Series: Assembling Pressure Tubing (March 31, 2020)

Video
5/11/2020
ICU Nursing Series: Assembling Pressure Tubing (March 31, 2020)

This video will review how to assemble pressure tubing to transduce pressures and waveforms from arterial lines and central lines. Connection to an ICU monitor with zeroing is also reviewed.

Recommended Content:

Coronavirus | Coronavirus and the COVID-19 Vaccine

Ventilator Tutorial V500/PB840 Drager (April 10, 2020)

Video
5/11/2020
Ventilator Tutorial V500/PB840 Drager (April 10, 2020)

Ventilator assembly and input of settings for two common ICU ventilators.

Recommended Content:

Coronavirus | Coronavirus and the COVID-19 Vaccine

Ventilator Basics (ACVC) (March 19, 2020)

Video
5/11/2020
Ventilator Basics (ACVC) (March 19, 2020)

Ventilator basics (one mode) for non-intensivists

Recommended Content:

Coronavirus | Coronavirus and the COVID-19 Vaccine

Shock Basics for the Non-Intensivist (March 19, 2020)

Video
5/11/2020
Shock Basics for the Non-Intensivist (March 19, 2020)

Shock Basics for the Non-Intensivist...in the age of COVID-19.

Recommended Content:

Coronavirus | Coronavirus and the COVID-19 Vaccine

Awakening Trials, Breathing Trials, and Extubation (March 27, 2020)

Video
5/11/2020
Awakening Trials, Breathing Trials, and Extubation (March 27, 2020)

This video covers safety screens and failure criteria for Spontaneous Awakening Trials (SATs) and Spontaneous Breathing Trials (SBTs). These together form the ABCs of daily care of ICU patients on vents (Airway and Breathing Coordination). Additionally, it covers the criteria that should be met prior to attempting extubation.

Recommended Content:

Coronavirus | Coronavirus and the COVID-19 Vaccine

Sepsis In The Age of COVID-19 (April 10, 2020)

Video
5/11/2020
Sepsis In The Age of COVID-19 (April 10, 2020)

This video will review diagnosis and management of sepsis with some clarifications/alterations that apply during the COVID pandemic. This video is not all inclusive. It is meant as a refresher for non-intensivists.

Recommended Content:

Coronavirus | Coronavirus and the COVID-19 Vaccine

Acid Base for the Non-intensivist (March 21, 2020)

Video
5/11/2020
Acid Base for the Non-intensivist (March 21, 2020)

This video will teach you the etiologies for the various acid-base disorders as well as teach you how to interpret an ABG with a focus on metabolic acidosis and mixed disorders. This will teach you little to nothing about buffering, organic chemistry, biochemistry, etc. This is for practical application at the bedside.

Recommended Content:

Coronavirus | Coronavirus and the COVID-19 Vaccine

BAMCheroes appreciation

Video
4/29/2020
BAMCheroes appreciation

Our community has been a great source of support! Check out some of the positive feedback Brooke Army Medical Center has received for our incredible healthcare professionals.

Recommended Content:

Coronavirus | Coronavirus and the COVID-19 Vaccine
<< < 1 2 3 4 5  ... > >> 
Showing results 61 - 75 Page 5 of 6

DHA Address: 7700 Arlington Boulevard | Suite 5101 | Falls Church, VA | 22042-5101

Some documents are presented in Portable Document Format (PDF). A PDF reader is required for viewing. Download a PDF Reader or learn more about PDFs.